Stay updated on Depemokimab in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page
- CheckyesterdayChange DetectedAdded a new trial site in Tainan, Taiwan (704) and updated the existing listing to display the location as Tainan (704) instead of Tainan City, Taiwan.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Study Record Dates section now shows the Results First Posted date (2024-11-29). Other study details remain unchanged.SummaryDifference0.2%

- Check44 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference2%

- Check51 days agoChange DetectedAdded Revision: v3.1.0 and removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) to align with a newer version.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new release, while the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.1%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.